178 related articles for article (PubMed ID: 24140867)
1. Cholera toxin breakdowns oral tolerance via activation of canonical NF-κB.
Kim KJ; Kim HA; Seo KH; Lee HK; Kang BY; Im SY
Cell Immunol; 2013; 285(1-2):92-9. PubMed ID: 24140867
[TBL] [Abstract][Full Text] [Related]
2. Alternate mucosal immune system: organized Peyer's patches are not required for IgA responses in the gastrointestinal tract.
Yamamoto M; Rennert P; McGhee JR; Kweon MN; Yamamoto S; Dohi T; Otake S; Bluethmann H; Fujihashi K; Kiyono H
J Immunol; 2000 May; 164(10):5184-91. PubMed ID: 10799877
[TBL] [Abstract][Full Text] [Related]
3. Oral tolerance induction by mucosal administration of cholera toxin B-coupled antigen involves T-cell proliferation in vivo and is not affected by depletion of CD25+ T cells.
George Chandy A; Hultkrantz S; Raghavan S; Czerkinsky C; Lebens M; Telemo E; Holmgren J
Immunology; 2006 Jul; 118(3):311-20. PubMed ID: 16827892
[TBL] [Abstract][Full Text] [Related]
4. Regional dichotomy of interleukin-4 and -5 regulation of senescent B cell responses specific for cholera toxin in Peyer's patches, lamina propria, and mesenteric lymph nodes.
Haq JA; Szewczuk MR
Reg Immunol; 1993; 5(1):60-7. PubMed ID: 8347471
[TBL] [Abstract][Full Text] [Related]
5. Oral tolerance revisited: prior oral tolerization abrogates cholera toxin-induced mucosal IgA responses.
Kato H; Fujihashi K; Kato R; Yuki Y; McGhee JR
J Immunol; 2001 Mar; 166(5):3114-21. PubMed ID: 11207263
[TBL] [Abstract][Full Text] [Related]
6. Cholera holotoxin and its B subunit enhance Peyer's patch B cell responses induced by orally administered influenza virus: disproportionate cholera toxin enhancement of the IgA B cell response.
Chen KS; Strober W
Eur J Immunol; 1990 Feb; 20(2):433-6. PubMed ID: 2311649
[TBL] [Abstract][Full Text] [Related]
7. IL-10 and IL-27 producing dendritic cells capable of enhancing IL-10 production of T cells are induced in oral tolerance.
Shiokawa A; Tanabe K; Tsuji NM; Sato R; Hachimura S
Immunol Lett; 2009 Jun; 125(1):7-14. PubMed ID: 19446579
[TBL] [Abstract][Full Text] [Related]
8. Regulation of mucosal dendritic cell function by receptor activator of NF-kappa B (RANK)/RANK ligand interactions: impact on tolerance induction.
Williamson E; Bilsborough JM; Viney JL
J Immunol; 2002 Oct; 169(7):3606-12. PubMed ID: 12244151
[TBL] [Abstract][Full Text] [Related]
9. Modulating dendritic cells to optimize mucosal immunization protocols.
Williamson E; Westrich GM; Viney JL
J Immunol; 1999 Oct; 163(7):3668-75. PubMed ID: 10490961
[TBL] [Abstract][Full Text] [Related]
10. Induction of antigen-specific regulatory T cells in the liver-draining celiac lymph node following oral antigen administration.
Hultkrantz S; Ostman S; Telemo E
Immunology; 2005 Nov; 116(3):362-72. PubMed ID: 16236126
[TBL] [Abstract][Full Text] [Related]
11. Enhanced immunological tolerance against allograft rejection by oral administration of allogeneic antigen linked to cholera toxin B subunit.
Sun JB; Li BL; Czerkinsky C; Holmgren J
Clin Immunol; 2000 Nov; 97(2):130-9. PubMed ID: 11027453
[TBL] [Abstract][Full Text] [Related]
12. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
Huibregtse IL; Snoeck V; de Creus A; Braat H; De Jong EC; Van Deventer SJ; Rottiers P
Gastroenterology; 2007 Aug; 133(2):517-28. PubMed ID: 17681173
[TBL] [Abstract][Full Text] [Related]
13. IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacter felis infection.
Bromander AK; Ekman L; Kopf M; Nedrud JG; Lycke NY
J Immunol; 1996 Jun; 156(11):4290-7. PubMed ID: 8666800
[TBL] [Abstract][Full Text] [Related]
14. Peyer's patches are required for oral tolerance to proteins.
Fujihashi K; Dohi T; Rennert PD; Yamamoto M; Koga T; Kiyono H; McGhee JR
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3310-5. PubMed ID: 11248075
[TBL] [Abstract][Full Text] [Related]
15. Release from Th1-type immune tolerance in spleen and enhanced production of IL-5 in Peyer's patch by cholera toxin B induce the glomerular deposition of IgA.
Yamanaka T; Tamauchi H; Suzuki Y; Suzuki H; Horikoshi S; Terashima M; Iwabuchi K; Habu S; Okumura K; Tomino Y
Immunobiology; 2016 Apr; 221(4):577-85. PubMed ID: 26719095
[TBL] [Abstract][Full Text] [Related]
16. Lack of antigen-specific immune responses in anti-IL-7 receptor alpha chain antibody-treated Peyer's patch-null mice following intestinal immunization with microencapsulated antigen.
Kunisawa J; Takahashi I; Okudaira A; Hiroi T; Katayama K; Ariyama T; Tsutsumi Y; Nakagawa S; Kiyono H; Mayumi T
Eur J Immunol; 2002 Aug; 32(8):2347-55. PubMed ID: 12209648
[TBL] [Abstract][Full Text] [Related]
17. Morphologic and functional alterations of mucosal T cells by cholera toxin and its B subunit.
Elson CO; Holland SP; Dertzbaugh MT; Cuff CF; Anderson AO
J Immunol; 1995 Feb; 154(3):1032-40. PubMed ID: 7822780
[TBL] [Abstract][Full Text] [Related]
18. Mesenteric lymph nodes are not required for an intestinal immunoglobulin A response to oral cholera toxin.
Hahn A; Thiessen N; Pabst R; Buettner M; Bode U
Immunology; 2010 Mar; 129(3):427-36. PubMed ID: 19922419
[TBL] [Abstract][Full Text] [Related]
19. Sublingual tolerance induction with antigen conjugated to cholera toxin B subunit induces Foxp3+CD25+CD4+ regulatory T cells and suppresses delayed-type hypersensitivity reactions.
Sun JB; Cuburu N; Blomquist M; Li BL; Czerkinsky C; Holmgren J
Scand J Immunol; 2006 Sep; 64(3):251-9. PubMed ID: 16918694
[TBL] [Abstract][Full Text] [Related]
20. The in vitro production of cytokines by mucosal lymphocytes immunized by oral administration of keyhole limpet hemocyanin using cholera toxin as an adjuvant.
Wilson AD; Bailey M; Williams NA; Stokes CR
Eur J Immunol; 1991 Oct; 21(10):2333-9. PubMed ID: 1833201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
